USPTO 2015–2025 USPTO PatentsView US Corporation

HDT Bio Corp.

USPTO PatentsView assignee record - 16 granted patents across 6 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

16
Total patents granted
6
CPC technology areas
30.9
Avg claims per patent
-
5-year filing velocity

The verdict

HDT holds 16 US patents across 6 technology areas, rank #17,730 of 50,000 tracked assignees.

#17,730
of 50,000 US assignees by volume
Top 9%
by Innovation Score (53.5/100)
30.9
avg claims per patent

Portfolio overview

HDT Bio Corp. has been granted 16 US utility patents between 2022 and 2025, placing HDT Bio Corp. at rank #17,730 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 30.9 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, HDT Bio Corp. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 53.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 16 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. HDT Bio Corp.'s 30.9 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark HDT Bio Corp. against peers pursuing similar technology classes.

How does HDT compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows HDT holds 16 patents, placing it at rank #17,730 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

HDT's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

1234567 2022202320242025 3
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
HDT Bio Corp. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 5 31.3%
2023 6 37.5%
2024 2 12.5%
2025 3 18.8%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex

Where it ranks

Overall rank by patents

#17,730

Across all tracked assignees

Innovation Score

53.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does HDT Bio Corp. hold?
HDT Bio Corp. holds 16 US granted patents filed between 2022 and 2025, spanning 6 technology areas.
What is HDT Bio Corp.'s Innovation Score?
HDT Bio Corp. has an Innovation Score of 53.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does HDT Bio Corp. focus on?
HDT Bio Corp.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 16 patents. The company has filed patents in 6 CPC subclasses total.
Is HDT Bio Corp.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for HDT Bio Corp..
What does claim depth mean for HDT Bio Corp.'s patents?
HDT Bio Corp.'s patents average 30.9 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the HDT Bio Corp. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How to use this portfolio

HDT's 16 grants land it in the top 9% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - HDT ranks #17,730 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.